COVID survivors frequently experience lingering neurological symptoms that resemble
cancer-therapy-related cognitive impairment, a syndrome for which white matter microglial …

Post-acute infection syndromes may develop after acute viral disease 1 . Infection with
SARS-CoV-2 can result in the development of a post-acute infection syndrome known as long …

Macrophages have a key role in shaping the tumour microenvironment (TME), tumour
immunity and response to immunotherapy, which makes them an important target for cancer …

Despite no apparent defects in T cell priming and recruitment to tumors, a large subset of T
cell rich tumors fail to respond to immune checkpoint blockade (ICB). We leveraged a …

The emergence of SARS-CoV-2 variants with mutations in major neutralizing antibody-binding
sites can affect humoral immunity induced by infection or vaccination 1 , 2 , 3 , 4 , 5 – 6 . …

Immunotherapy is a mainstay of non-small cell lung cancer (NSCLC) management. While
tumor mutational burden (TMB) correlates with response to immunotherapy, little is known …

The cellular and molecular programs driving T-cell marginalization in solid tumors remain
unclear. Here, we describe two CAF populations associated with T-cell exclusion in human …

Although it has been more than 2 years since the start of the coronavirus disease 2019 (COVID-19)
pandemic, COVID-19 continues to be a worldwide health crisis. Despite the …

Survivors of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection
frequently experience lingering neurological symptoms, including impairment in attention, …

Multisystem inflammatory syndrome in children (MIS-C) presents with fever, inflammation
and pathology of multiple organs in individuals under 21 years of age in the weeks following …